Cross-Sectional Evaluation of Persistence of SARS-CoV-2 Remnants After Recovery From Acute Infection
Summary:
Type:
Status:
Locations:
Bethesda, United States
Last Updated:
June 12, 2025
RECOVER-ENERGIZE Platform Protocol_Appendix A (Exercise Intolerance)
Summary:
Type:
Status:
Interventions:
Personalized Cardiopulmonary Rehabilitation, Education
Locations:
Durham, United States
Last Updated:
June 12, 2025
PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
Summary:
Type:
Status:
Interventions:
11C-PS13
Locations:
Bethesda, United States
Last Updated:
June 12, 2025
RECOVER-SLEEP: Platform Protocol
Summary:
Type:
Status:
Interventions:
Modafinil, Modafinil Placebo, Solriamfetol, Solriamfetol Placebo, Melatonin, Melantonin Placebo, Tailored lighting (TL) Active, Tailored lighting (TL) Placebo
Locations:
Phoenix, United States; Tucson, United States; and 42 more
Last Updated:
June 11, 2025
Post COVID-19 Syndrome Treatment With Variable Pulse Transcranial Magnetic Stimulation
Summary:
Type:
Status:
Interventions:
Electromagnetic Brain Pulsing Variable Pulse Protocol (EMBP) - 2 weeks, Electromagnetic Brain Pulsing Variable Pulse Protocol (EMBP) - 4 weeks
Locations:
Rochester, United States
Last Updated:
June 10, 2025
Fatigability in Long COVID-19
Summary:
Type:
Status:
Interventions:
Minimal-Dose Home-Based Resistance Exercise
Locations:
Washington, United States
Last Updated:
June 10, 2025
Long-term Impact of Infection With Novel Coronavirus (COVID-19)
Summary:
Type:
Status:
Locations:
San Francisco, United States
Last Updated:
June 9, 2025
Long COVID Cutaneous Signatures: An ARPA Funded Research Project
Summary:
Type:
Status:
Locations:
Scottsdale, United States
Last Updated:
June 3, 2025
Probiotic Use for Recovery Enhancement From Long COVID-19
Summary:
Type:
Status:
Interventions:
Probiotic Agent, Placebo
Locations:
Chicago, United States
Last Updated:
June 3, 2025
NE3107 in Adults With Neurological Symptoms of Long COVID
Summary:
Type:
Status:
Interventions:
NE3107, Placebo
Locations:
San Francisco, United States; Jacksonville, United States; and 3 more
Last Updated:
June 2, 2025